BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Castro-Dopico T, Dennison TW, Ferdinand JR, Mathews RJ, Fleming A, Clift D, Stewart BJ, Jing C, Strongili K, Labzin LI, Monk EJM, Saeb-Parsy K, Bryant CE, Clare S, Parkes M, Clatworthy MR. Anti-commensal IgG Drives Intestinal Inflammation and Type 17 Immunity in Ulcerative Colitis. Immunity 2019;50:1099-1114.e10. [PMID: 30876876 DOI: 10.1016/j.immuni.2019.02.006] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 19.3] [Reference Citation Analysis]
Number Citing Articles
1 Nowak JK, Szymańska CJ, Glapa-nowak A, Duclaux-loras R, Dybska E, Ostrowski J, Walkowiak J, Adams AT. Unexpected Actors in Inflammatory Bowel Disease Revealed by Machine Learning from Whole-Blood Transcriptomic Data. Genes 2022;13:1570. [DOI: 10.3390/genes13091570] [Reference Citation Analysis]
2 Vujkovic-Cvijin I, Welles HC, Ha CWY, Huq L, Mistry S, Brenchley JM, Trinchieri G, Devkota S, Belkaid Y. The systemic anti-microbiota IgG repertoire can identify gut bacteria that translocate across gut barrier surfaces. Sci Transl Med 2022;14:eabl3927. [PMID: 35976997 DOI: 10.1126/scitranslmed.abl3927] [Reference Citation Analysis]
3 Huang L, Zheng J, Sun G, Yang H, Sun X, Yao X, Lin A, Liu H. 5-Aminosalicylic acid ameliorates dextran sulfate sodium-induced colitis in mice by modulating gut microbiota and bile acid metabolism. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-022-04471-3] [Reference Citation Analysis]
4 Qi Q, Zhong R, Liu YN, Zhao C, Huang Y, Lu Y, Ma Z, Zheng HD, Wu LY. Mechanism of electroacupuncture and herb-partitioned moxibustion on ulcerative colitis animal model: A study based on proteomics. World J Gastroenterol 2022; 28(28): 3644-3665 [DOI: 10.3748/wjg.v28.i28.3644] [Reference Citation Analysis]
5 Bian Z, Qin Y, Li L, Su L, Fei C, Li Y, Hu M, Chen X, Zhang W, Mao C, Yuan X, Lu T, Ji. Schisandra chinensis (Turcz.) Baill. Protects against DSS-induced colitis in mice: Involvement of TLR4/NF-κB/NLRP3 inflammasome pathway and gut microbiota. J Ethnopharmacol 2022;:115570. [PMID: 35868549 DOI: 10.1016/j.jep.2022.115570] [Reference Citation Analysis]
6 Mei C, Meng F, Wang X, Yan S, Zheng Q, Zhang X, Fu W, Xue J, Wang S, He Y, Sun X, Jiang X, Wang Y. CD30L is involved in the regulation of the inflammatory response through inducing homing and differentiation of monocytes via CCL2/CCR2 axis and NF-κB pathway in mice with colitis. Int Immunopharmacol 2022;110:108934. [PMID: 35834956 DOI: 10.1016/j.intimp.2022.108934] [Reference Citation Analysis]
7 van Unen V, Ouboter LF, Li N, Schreurs M, Abdelaal T, Kooy-winkelaar Y, Beyrend G, Höllt T, Maljaars PWJ, Mearin ML, Mahfouz A, Witte AMC, Clemens CHM, Abraham S, Escher JC, Lelieveldt BPF, Pascutti MF, van der Meulen – de Jong AE, Koning F. Identification of a Disease-Associated Network of Intestinal Immune Cells in Treatment-Naive Inflammatory Bowel Disease. Front Immunol 2022;13:893803. [DOI: 10.3389/fimmu.2022.893803] [Reference Citation Analysis]
8 Maccio-Maretto L, Piqueras V, Barrios BE, Romagnoli PA, Denning TL, Correa SG. Luminal bacteria coated with IgA and IgG during intestinal inflammation as a new and abundant stimulus for colonic macrophages. Immunology 2022. [PMID: 35689599 DOI: 10.1111/imm.13518] [Reference Citation Analysis]
9 Fu W, Wang W, Zhang J, Zhao Y, Chen K, Wang Y, Zhang J, Xiong Y, Guo X, Ding S. Dynamic change of circulating innate and adaptive lymphocytes subtypes during a cascade of gastric lesions. J Leukoc Biol 2022. [PMID: 35657091 DOI: 10.1002/JLB.5MA0422-505R] [Reference Citation Analysis]
10 Posner DA, Lee CY, Portet A, Clatworthy MR. Humoral immunity at the brain borders in homeostasis. Current Opinion in Immunology 2022;76:102188. [DOI: 10.1016/j.coi.2022.102188] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Kim DW, Jeong HS, Kim E, Lee H, Choi CH, Lee SJ. Oral delivery of stem-cell-loaded hydrogel microcapsules restores gut inflammation and microbiota. J Control Release 2022:S0168-3659(22)00291-7. [PMID: 35597403 DOI: 10.1016/j.jconrel.2022.05.028] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Al-rashidi HE. Gut microbiota and immunity relevance in eubiosis and dysbiosis. Saudi Journal of Biological Sciences 2022;29:1628-43. [DOI: 10.1016/j.sjbs.2021.10.068] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
13 Uzzan M, Martin JC, Mesin L, Livanos AE, Castro-dopico T, Huang R, Petralia F, Magri G, Kumar S, Zhao Q, Rosenstein AK, Tokuyama M, Sharma K, Ungaro R, Kosoy R, Jha D, Fischer J, Singh H, Keir ME, Ramamoorthi N, Gorman WEO, Cohen BL, Rahman A, Cossarini F, Seki A, Leyre L, Vaquero ST, Gurunathan S, Grasset EK, Losic B, Dubinsky M, Greenstein AJ, Gottlieb Z, Legnani P, George J, Irizar H, Stojmirovic A, Brodmerkel C, Kasarkis A, Sands BE, Furtado G, Lira SA, Tuong ZK, Ko HM, Cerutti A, Elson CO, Clatworthy MR, Merad M, Suárez-fariñas M, Argmann C, Hackney JA, Victora GD, Randolph GJ, Kenigsberg E, Colombel JF, Mehandru S. Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity. Nat Med. [DOI: 10.1038/s41591-022-01680-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Kałużna A, Olczyk P, Komosińska-Vassev K. The Role of Innate and Adaptive Immune Cells in the Pathogenesis and Development of the Inflammatory Response in Ulcerative Colitis. J Clin Med 2022;11:400. [PMID: 35054093 DOI: 10.3390/jcm11020400] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
15 Fleming A, Castro-Dopico T, Clatworthy MR. B cell class switching in intestinal immunity in health and disease. Scand J Immunol 2022;95:e13139. [PMID: 34978077 DOI: 10.1111/sji.13139] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
16 Zhao Q, Maynard CL. Mucus, commensals, and the immune system. Gut Microbes 2022;14:2041342. [PMID: 35239459 DOI: 10.1080/19490976.2022.2041342] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Chalayer E, Gramont B, Zekre F, Goguyer-Deschaumes R, Waeckel L, Grange L, Paul S, Chung AW, Killian M. Fc receptors gone wrong: A comprehensive review of their roles in autoimmune and inflammatory diseases. Autoimmun Rev 2021;21:103016. [PMID: 34915182 DOI: 10.1016/j.autrev.2021.103016] [Reference Citation Analysis]
18 Nakase H, Sato N, Mizuno N, Ikawa Y. The influence of cytokines on the complex pathology of ulcerative colitis. Autoimmun Rev 2021;:103017. [PMID: 34902606 DOI: 10.1016/j.autrev.2021.103017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
19 Huang RY, Lee CN, Moochhala S. Circulating Antibodies to Skin Bacteria Detected by Serological Lateral Flow Immunoassays Differentially Correlated With Bacterial Abundance. Front Microbiol 2021;12:709562. [PMID: 34867837 DOI: 10.3389/fmicb.2021.709562] [Reference Citation Analysis]
20 Goguyer-Deschaumes R, Waeckel L, Killian M, Rochereau N, Paul S. Metabolites and secretory immunoglobulins: messengers and effectors of the host-microbiota intestinal equilibrium. Trends Immunol 2022;43:63-77. [PMID: 34848167 DOI: 10.1016/j.it.2021.11.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Parrish A, Boudaud M, Kuehn A, Ollert M, Desai MS. Intestinal mucus barrier: a missing piece of the puzzle in food allergy. Trends Mol Med 2022;28:36-50. [PMID: 34810087 DOI: 10.1016/j.molmed.2021.10.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
22 Li R, Chen C, Liu B, Shi W, Shimizu K, Zhang C. Bryodulcosigenin a natural cucurbitane-type triterpenoid attenuates dextran sulfate sodium (DSS)-induced colitis in mice. Phytomedicine 2022;94:153814. [PMID: 34798522 DOI: 10.1016/j.phymed.2021.153814] [Reference Citation Analysis]
23 Casalegno Garduño R, Däbritz J. New Insights on CD8+ T Cells in Inflammatory Bowel Disease and Therapeutic Approaches. Front Immunol 2021;12:738762. [PMID: 34707610 DOI: 10.3389/fimmu.2021.738762] [Reference Citation Analysis]
24 Friedrich M, Pohin M, Jackson MA, Korsunsky I, Bullers SJ, Rue-Albrecht K, Christoforidou Z, Sathananthan D, Thomas T, Ravindran R, Tandon R, Peres RS, Sharpe H, Wei K, Watts GFM, Mann EH, Geremia A, Attar M, McCuaig S, Thomas L, Collantes E, Uhlig HH, Sansom SN, Easton A, Raychaudhuri S, Travis SP, Powrie FM; Oxford IBD Cohort Investigators., Roche Fibroblast Network Consortium. IL-1-driven stromal-neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies. Nat Med 2021;27:1970-81. [PMID: 34675383 DOI: 10.1038/s41591-021-01520-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
25 Duan L, Cheng S, Li L, Liu Y, Wang D, Liu G. Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease. Front Pharmacol 2021;12:684486. [PMID: 34335253 DOI: 10.3389/fphar.2021.684486] [Reference Citation Analysis]
26 Xu X, Li J, Long X, Tao S, Yu X, Ruan X, Zhao K, Tian L. C646 Protects Against DSS-Induced Colitis Model by Targeting NLRP3 Inflammasome. Front Pharmacol 2021;12:707610. [PMID: 34322027 DOI: 10.3389/fphar.2021.707610] [Reference Citation Analysis]
27 Zhou J, Liu J, Gao Y, Shen L, Li S, Chen S. miRNA-Based Potential Biomarkers and New Molecular Insights in Ulcerative Colitis. Front Pharmacol 2021;12:707776. [PMID: 34305614 DOI: 10.3389/fphar.2021.707776] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Chiu CJ, Chang ML, Kantarci A, Van Dyke TE, Shi W. Exposure to Porphyromonas gingivalis and Modifiable Risk Factors Modulate Risk for Early Diabetic Retinopathy. Transl Vis Sci Technol 2021;10:23. [PMID: 34003908 DOI: 10.1167/tvst.10.2.23] [Reference Citation Analysis]
29 Maasfeh L, Hartlova A, Isaksson S, Sundin J, Mavroudis G, Savolainen O, Strid H, Öhman L, Magnusson MK. Impaired Luminal Control of Intestinal Macrophage Maturation in Patients With Ulcerative Colitis During Remission. Cell Mol Gastroenterol Hepatol 2021:S2352-345X(21)00119-3. [PMID: 34126236 DOI: 10.1016/j.jcmgh.2021.06.004] [Reference Citation Analysis]
30 Aschenbrenner D, Quaranta M, Banerjee S, Ilott N, Jansen J, Steere B, Chen YH, Ho S, Cox K, Arancibia-Cárcamo CV, Coles M, Gaffney E, Travis SP, Denson L, Kugathasan S, Schmitz J, Powrie F, Sansom SN, Uhlig HH. Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistance. Gut 2021;70:1023-36. [PMID: 33037057 DOI: 10.1136/gutjnl-2020-321731] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 17.0] [Reference Citation Analysis]
31 Wang W, Xu C, Li X, Wang Z, Yang J, Shen Y, Shi M, Chen L, Zhang L, Guo Y, Wang B, Zhang T, Pu Y. Exploration of the potential mechanism of Banxia Xiexin Decoction for the effects on TNBS-induced ulcerative colitis rats with the assistance of network pharmacology analysis. J Ethnopharmacol 2021;277:114197. [PMID: 34004261 DOI: 10.1016/j.jep.2021.114197] [Reference Citation Analysis]
32 Reens AL, Cabral DJ, Liang X, Norton JE Jr, Therien AG, Hazuda DJ, Swaminathan G. Immunomodulation by the Commensal Microbiome During Immune-Targeted Interventions: Focus on Cancer Immune Checkpoint Inhibitor Therapy and Vaccination. Front Immunol 2021;12:643255. [PMID: 34054810 DOI: 10.3389/fimmu.2021.643255] [Reference Citation Analysis]
33 Geyer CE, Mes L, Newling M, den Dunnen J, Hoepel W. Physiological and Pathological Inflammation Induced by Antibodies and Pentraxins. Cells 2021;10:1175. [PMID: 34065953 DOI: 10.3390/cells10051175] [Reference Citation Analysis]
34 Castro-Dopico T, Fleming A, Dennison TW, Ferdinand JR, Harcourt K, Stewart BJ, Cader Z, Tuong ZK, Jing C, Lok LSC, Mathews RJ, Portet A, Kaser A, Clare S, Clatworthy MR. GM-CSF Calibrates Macrophage Defense and Wound Healing Programs during Intestinal Infection and Inflammation. Cell Rep 2020;32:107857. [PMID: 32640223 DOI: 10.1016/j.celrep.2020.107857] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
35 Caliskan M, Brown CD, Maranville JC. A catalog of GWAS fine-mapping efforts in autoimmune disease. Am J Hum Genet 2021;108:549-63. [PMID: 33798443 DOI: 10.1016/j.ajhg.2021.03.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
36 Landuyt AE, Klocke BJ, Duck LW, Kemp KM, Muir RQ, Jennings MS, Blum SI, Tse HM, Lee G, Morrow CD, Elson CO, Maynard CL. ICOS ligand and IL-10 synergize to promote host-microbiota mutualism. Proc Natl Acad Sci U S A 2021;118:e2018278118. [PMID: 33753483 DOI: 10.1073/pnas.2018278118] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Prins MM, Verstockt B, Ferrante M, Vermeire S, Wildenberg ME, Koelink PJ. Monocyte TREM-1 Levels Associate With Anti-TNF Responsiveness in IBD Through Autophagy and Fcγ-Receptor Signaling Pathways. Front Immunol 2021;12:627535. [PMID: 33790898 DOI: 10.3389/fimmu.2021.627535] [Reference Citation Analysis]
38 Grasset EK, Cerutti A. Mutations make gut antibodies promiscuous. J Exp Med 2020;217:e20201340. [PMID: 32960963 DOI: 10.1084/jem.20201340] [Reference Citation Analysis]
39 Li G, Zhang B, Hao J, Chu X, Wiestler M, Cornberg M, Xu CJ, Liu X, Li Y. Identification of Novel Population-Specific Cell Subsets in Chinese Ulcerative Colitis Patients Using Single-Cell RNA Sequencing. Cell Mol Gastroenterol Hepatol 2021;12:99-117. [PMID: 33545427 DOI: 10.1016/j.jcmgh.2021.01.020] [Reference Citation Analysis]
40 Jackson MA, Pearson C, Ilott NE, Huus KE, Hegazy AN, Webber J, Finlay BB, Macpherson AJ, Powrie F, Lam LH. Accurate identification and quantification of commensal microbiota bound by host immunoglobulins. Microbiome 2021;9:33. [PMID: 33516266 DOI: 10.1186/s40168-020-00992-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
41 Rochereau N, Roblin X, Michaud E, Gayet R, Chanut B, Jospin F, Corthésy B, Paul S. NOD2 deficiency increases retrograde transport of secretory IgA complexes in Crohn's disease. Nat Commun 2021;12:261. [PMID: 33431850 DOI: 10.1038/s41467-020-20348-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
42 Caetano AJ, Yianni V, Volponi A, Booth V, D'Agostino EM, Sharpe P. Defining human mesenchymal and epithelial heterogeneity in response to oral inflammatory disease. Elife 2021;10:e62810. [PMID: 33393902 DOI: 10.7554/eLife.62810] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
43 Koscsó B, Kurapati S, Rodrigues RR, Nedjic J, Gowda K, Shin C, Soni C, Ashraf AZ, Purushothaman I, Palisoc M, Xu S, Sun H, Chodisetti SB, Lin E, Mack M, Kawasawa YI, He P, Rahman ZSM, Aifantis I, Shulzhenko N, Morgun A, Bogunovic M. Gut-resident CX3CR1hi macrophages induce tertiary lymphoid structures and IgA response in situ. Sci Immunol 2020;5:eaax0062. [PMID: 32276965 DOI: 10.1126/sciimmunol.aax0062] [Cited by in Crossref: 13] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
44 Cutone A, Ianiro G, Lepanto MS, Rosa L, Valenti P, Bonaccorsi di Patti MC, Musci G. Lactoferrin in the Prevention and Treatment of Intestinal Inflammatory Pathologies Associated with Colorectal Cancer Development. Cancers (Basel) 2020;12:E3806. [PMID: 33348646 DOI: 10.3390/cancers12123806] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Castro-Dopico T, Colombel JF, Mehandru S. Targeting B cells for inflammatory bowel disease treatment: back to the future. Curr Opin Pharmacol 2020;55:90-8. [PMID: 33166872 DOI: 10.1016/j.coph.2020.10.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
46 Bauché D, Mauze S, Kochel C, Grein J, Sawant A, Zybina Y, Blumenschein W, Yang P, Annamalai L, Yearley JH, Punnonen J, Bowman EP, Chackerian A, Laface D. Antitumor efficacy of combined CTLA4/PD-1 blockade without intestinal inflammation is achieved by elimination of FcγR interactions. J Immunother Cancer 2020;8:e001584. [PMID: 33127658 DOI: 10.1136/jitc-2020-001584] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
47 Qiao S, Lv C, Tao Y, Miao Y, Zhu Y, Zhang W, Sun D, Yun X, Xia Y, Wei Z, Dai Y. Arctigenin disrupts NLRP3 inflammasome assembly in colonic macrophages via downregulating fatty acid oxidation to prevent colitis-associated cancer. Cancer Letters 2020;491:162-79. [DOI: 10.1016/j.canlet.2020.08.033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
48 Jia J, Zheng K, Shen H, Yu J, Zhu P, Yan S, Xu Y, Zhu L, Lu Y, Gu P, Feng W. Qingchang Huashi granule ameliorates experimental colitis via restoring the dendritic cell-mediated Th17/Treg balance. BMC Complement Med Ther 2020;20:291. [PMID: 32967687 DOI: 10.1186/s12906-020-03088-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Yun X, Fang Y, Lv C, Qiao S, Tao Y, Dai Y, Xia Y. Inhibition of the activation of γδT17 cells through PPARγ-PTEN/Akt/GSK3β/NFAT pathway contributes to the anti-colitis effect of madecassic acid. Cell Death Dis 2020;11:752. [PMID: 32929062 DOI: 10.1038/s41419-020-02969-x] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
50 Boland BS, He Z, Tsai MS, Olvera JG, Omilusik KD, Duong HG, Kim ES, Limary AE, Jin W, Milner JJ, Yu B, Patel SA, Louis TL, Tysl T, Kurd NS, Bortnick A, Quezada LK, Kanbar JN, Miralles A, Huylebroeck D, Valasek MA, Dulai PS, Singh S, Lu LF, Bui JD, Murre C, Sandborn WJ, Goldrath AW, Yeo GW, Chang JT. Heterogeneity and clonal relationships of adaptive immune cells in ulcerative colitis revealed by single-cell analyses. Sci Immunol 2020;5:eabb4432. [PMID: 32826341 DOI: 10.1126/sciimmunol.abb4432] [Cited by in Crossref: 21] [Cited by in F6Publishing: 36] [Article Influence: 10.5] [Reference Citation Analysis]
51 Donovan C, Liu G, Shen S, Marshall JE, Kim RY, Alemao CA, Budden KF, Choi JP, Kohonen-Corish M, El-Omar EM, Yang IA, Hansbro PM. The role of the microbiome and the NLRP3 inflammasome in the gut and lung. J Leukoc Biol 2020;108:925-35. [PMID: 33405294 DOI: 10.1002/JLB.3MR0720-472RR] [Cited by in Crossref: 2] [Cited by in F6Publishing: 25] [Article Influence: 1.0] [Reference Citation Analysis]
52 Hoepel W, Golebski K, van Drunen CM, den Dunnen J. Active control of mucosal tolerance and inflammation by human IgA and IgG antibodies. Journal of Allergy and Clinical Immunology 2020;146:273-5. [DOI: 10.1016/j.jaci.2020.04.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
53 Wu N, Chen D, Sun H, Tan J, Zhang Y, Zhang T, Han Y, Liu H, Ouyang X, Yang XD, Niu X, Zhong J, Wang Z, Su B. MAP3K2 augments Th1 cell differentiation via IL-18 to promote T cell-mediated colitis. Sci China Life Sci 2021;64:389-403. [PMID: 32737854 DOI: 10.1007/s11427-020-1720-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
54 Huus KE, Rodriguez-Pozo A, Kapel N, Nestoret A, Habib A, Dede M, Manges A, Collard JM, Sansonetti PJ, Vonaesch P, Finlay BB; Afribiota Investigators. Immunoglobulin recognition of fecal bacteria in stunted and non-stunted children: findings from the Afribiota study. Microbiome 2020;8:113. [PMID: 32718353 DOI: 10.1186/s40168-020-00890-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
55 Kappler K, Lasanajak Y, Smith DF, Opitz L, Hennet T. Increased Antibody Response to Fucosylated Oligosaccharides and Fucose-Carrying Bacteroides Species in Crohn's Disease. Front Microbiol 2020;11:1553. [PMID: 32765449 DOI: 10.3389/fmicb.2020.01553] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
56 Ruff WE, Greiling TM, Kriegel MA. Host-microbiota interactions in immune-mediated diseases. Nat Rev Microbiol 2020;18:521-38. [PMID: 32457482 DOI: 10.1038/s41579-020-0367-2] [Cited by in Crossref: 53] [Cited by in F6Publishing: 103] [Article Influence: 26.5] [Reference Citation Analysis]
57 Huang B, Chen Z, Geng L, Wang J, Liang H, Cao Y, Chen H, Huang W, Su M, Wang H, Xu Y, Liu Y, Lu B, Xian H, Li H, Li H, Ren L, Xie J, Ye L, Wang H, Zhao J, Chen P, Zhang L, Zhao S, Zhang T, Xu B, Che D, Si W, Gu X, Zeng L, Wang Y, Li D, Zhan Y, Delfouneso D, Lew AM, Cui J, Tang WH, Zhang Y, Gong S, Bai F, Yang M, Zhang Y. Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways. Cell 2019;179:1160-1176.e24. [PMID: 31730855 DOI: 10.1016/j.cell.2019.10.027] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 22.0] [Reference Citation Analysis]
58 Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res 2020;30:492-506. [PMID: 32433595 DOI: 10.1038/s41422-020-0332-7] [Cited by in Crossref: 410] [Cited by in F6Publishing: 1] [Article Influence: 205.0] [Reference Citation Analysis]
59 Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res 2020;30:492-506. [PMID: 32433595 DOI: 10.1038/s41422-020-0332-7] [Cited by in Crossref: 226] [Cited by in F6Publishing: 593] [Article Influence: 113.0] [Reference Citation Analysis]
60 Xiaoyu P, Chao G, Lihua D, Pengyu C. Gut bacteria affect the tumoral immune milieu: distorting the efficacy of immunotherapy or not?. Gut Microbes 2020;11:691-705. [PMID: 32216675 DOI: 10.1080/19490976.2020.1739794] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Graham DB, Xavier RJ. Pathway paradigms revealed from the genetics of inflammatory bowel disease. Nature 2020;578:527-39. [PMID: 32103191 DOI: 10.1038/s41586-020-2025-2] [Cited by in Crossref: 78] [Cited by in F6Publishing: 156] [Article Influence: 39.0] [Reference Citation Analysis]
62 James KR, Gomes T, Elmentaite R, Kumar N, Gulliver EL, King HW, Stares MD, Bareham BR, Ferdinand JR, Petrova VN, Polański K, Forster SC, Jarvis LB, Suchanek O, Howlett S, James LK, Jones JL, Meyer KB, Clatworthy MR, Saeb-Parsy K, Lawley TD, Teichmann SA. Distinct microbial and immune niches of the human colon. Nat Immunol 2020;21:343-53. [PMID: 32066951 DOI: 10.1038/s41590-020-0602-z] [Cited by in Crossref: 66] [Cited by in F6Publishing: 71] [Article Influence: 33.0] [Reference Citation Analysis]
63 Oh WS, Jung JC, Choi YM, Mun JY, Ku SK, Song CH. Protective effects of fermented rice extract on ulcerative colitis induced by dextran sodium sulfate in mice. Food Sci Nutr 2020;8:1718-28. [PMID: 32180979 DOI: 10.1002/fsn3.1460] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
64 Liu Y, Duan Y, Li Y. Integrated Gene Expression Profiling Analysis Reveals Probable Molecular Mechanism and Candidate Biomarker in Anti-TNFα Non-Response IBD Patients. J Inflamm Res 2020;13:81-95. [PMID: 32104045 DOI: 10.2147/JIR.S236262] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
65 Chen K, Magri G, Grasset EK, Cerutti A. Rethinking mucosal antibody responses: IgM, IgG and IgD join IgA. Nat Rev Immunol 2020;20:427-41. [PMID: 32015473 DOI: 10.1038/s41577-019-0261-1] [Cited by in Crossref: 58] [Cited by in F6Publishing: 75] [Article Influence: 29.0] [Reference Citation Analysis]
66 Soderholm AT, Pedicord VA. Intestinal epithelial cells: at the interface of the microbiota and mucosal immunity. Immunology 2019;158:267-80. [PMID: 31509239 DOI: 10.1111/imm.13117] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 12.0] [Reference Citation Analysis]
67 Nagelkerke SQ, Schmidt DE, de Haas M, Kuijpers TW. Genetic Variation in Low-To-Medium-Affinity Fcγ Receptors: Functional Consequences, Disease Associations, and Opportunities for Personalized Medicine. Front Immunol 2019;10:2237. [PMID: 31632391 DOI: 10.3389/fimmu.2019.02237] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
68 Castro-Dopico T, Clatworthy MR. Mucosal IgG in inflammatory bowel disease - a question of (sub)class? Gut Microbes 2020;12:1-9. [PMID: 31480888 DOI: 10.1080/19490976.2019.1651596] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
69 Foss S, Bottermann M, Jonsson A, Sandlie I, James LC, Andersen JT. TRIM21-From Intracellular Immunity to Therapy. Front Immunol 2019;10:2049. [PMID: 31555278 DOI: 10.3389/fimmu.2019.02049] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 7.7] [Reference Citation Analysis]
70 Neurath MF. Targeting immune cell circuits and trafficking in inflammatory bowel disease. Nat Immunol 2019;20:970-9. [PMID: 31235952 DOI: 10.1038/s41590-019-0415-0] [Cited by in Crossref: 136] [Cited by in F6Publishing: 208] [Article Influence: 45.3] [Reference Citation Analysis]
71 Newling M, Sritharan L, van der Ham AJ, Hoepel W, Fiechter RH, de Boer L, Zaat SAJ, Bisoendial RJ, Baeten DLP, Everts B, den Dunnen J. C-Reactive Protein Promotes Inflammation through FcγR-Induced Glycolytic Reprogramming of Human Macrophages. J Immunol 2019;203:225-35. [PMID: 31118224 DOI: 10.4049/jimmunol.1900172] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
72 Castro-Dopico T, Clatworthy MR. IgG and Fcγ Receptors in Intestinal Immunity and Inflammation. Front Immunol 2019;10:805. [PMID: 31031776 DOI: 10.3389/fimmu.2019.00805] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
73 Chen HH, Simmons A. Becalming Type 17 Inflammation in Ulcerative Colitis. Immunity 2019;50:1029-31. [DOI: 10.1016/j.immuni.2019.03.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]